| 产品编号 |
英文名称 |
CAS号 |
产品规格 |
价格 |
货期 |
| ZMR-15-5966 |
(11aS)-10,11,12,13-Tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee) |
[1258327-03-5] |
100mg |
咨询 |
3-5周 |
| ZMR-15-0508 |
(11aS)-3,7-Bis(4-methoxyphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98% (99% ee) |
N/A |
50mg |
咨询 |
3-5周 |
| ZMR-15-8570 |
(11aS)-3,7-Di-9-anthracenyl-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 95%, (99% ee) |
N/A |
100mg |
咨询 |
3-5周 |
| ZMR-15-0335 |
(11aS)-3,7-Di-9-anthracenyl-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee) |
[1393527-23-5] |
25mg |
咨询 |
3-5周 |
| ZMR-15-8579 |
(11aS)-3,7-Bis((4-(1,1-dimethylethyl)phenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 95%, (99% ee) |
N/A |
100mg |
咨询 |
3-5周 |
| ZMR-15-0338 |
(11aS)-3,7-Bis((4-(1,1-dimethylethyl)phenyl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee) |
N/A |
25mg |
咨询 |
3-5周 |
| ZMR-15-0278 |
(11aS)-3,7-Bis(1-pyrenyl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin |
N/A |
25mg |
咨询 |
3-5周 |
| ZMR-15-0516 |
(11aS)-3,7-Bis(3,5-dichlorophenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98% (99% ee) |
N/A |
50mg |
咨询 |
3-5周 |
| ZMR-15-8563 |
(11aS)-3,7-Bis(3,5-dimethylphenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee) |
N/A |
100mg |
咨询 |
3-5周 |
| ZMR-15-0543 |
(11aS)-3,7-Bis(3,5-dimethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, min. 98% |
[1412439-82-7] |
100mg |
咨询 |
3-5周 |
| ZMR-15-8581 |
(11aS)-3,7-Bis(4-(trifluoromethyl)phenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 95%, (99% ee) |
N/A |
100mg |
咨询 |
3-5周 |
| ZMR-15-0492 |
(11aS)-3,7-Bis(4-(trifluoromethyl)phenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98% (99% ee) |
N/A |
50mg |
咨询 |
3-5周 |
| ZMR-15-0275 |
(11aS)-3,7-Bis(4-chlorophenyl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee) |
[1258327-05-7] |
50mg |
咨询 |
3-5周 |
| ZMR-15-8585 |
(11aS)-3,7-Bis(4-nitrophenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 95%, (99% ee) |
N/A |
100mg |
咨询 |
3-5周 |
| ZMR-15-0512 |
(11aS)-3,7-Bis(4-nitrophenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98% (99% ee) |
[1412439-84-9] |
50mg |
咨询 |
3-5周 |
| ZMR-15-0524 |
(11aS)-3,7-Bis(triphenylsilyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98% (99% ee) |
N/A |
50mg |
咨询 |
3-5周 |
| ZMR-15-0464 |
(11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-bis[2,4,6-trisisopropylphenyl]-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98% (99% ee) |
[1258276-28-6] |
50mg |
咨询 |
3-5周 |
| ZMR-15-0528 |
(11aS)-3,7-Bis[3,5-bis(trifluoromethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, min. 98% |
[1258327-07-9] |
100mg |
咨询 |
3-5周 |
| ZMR-15-8589 |
(11aS)-3,7-Bis[3,5-bis(tert-butyl)-4-methoxyphenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee) |
N/A |
100mg |
咨询 |
3-5周 |
| ZMR-15-0534 |
(11aS)-3,7-Bis[3,5-bis(tert-butyl)-4-methoxyphenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98% (99% ee) |
N/A |
50mg |
咨询 |
3-5周 |
| ZMR-15-8593 |
(11aS)-3,7-Bis[3,5-bis(tert-butyl)phenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee) |
N/A |
100mg |
咨询 |
3-5周 |
| ZMR-15-0578 |
(11aS)-3,7-Bis[3,5-bis(tert-butyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee) |
N/A |
100mg |
咨询 |
3-5周 |
| ZMR-15-0564 |
(11aS)-3,7-Bis[3,5-bis[3,5-bis(trifluoromethyl)phenyl]phenyl]-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee) |
N/A |
100mg |
咨询 |
3-5周 |
| ZMR-15-0548 |
(11aS)-3,7-Bis[4-(2-naphthalenyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98% (99% ee) |
N/A |
50mg |
咨询 |
3-5周 |
| ZMR-15-0368 |
(11bR)-2,6-Bis(4-chlorophenyl)-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98% (99% ee) |
[922711-71-5] |
50mg |
咨询 |
3-5周 |
| ZMR-15-0384 |
(11bR)-2,6-Bis(4-chlorophenyl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98% (99% ee) |
[915038-16-3] |
50mg |
咨询 |
3-5周 |
| ZMR-15-0364 |
(11bR)-2,6-Di-1-pyrenyl-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98%, (99% ee) |
N/A |
50mg |
咨询 |
3-5周 |
| ZMR-15-0552 |
(11bR)-2,6-Di-9-phenanthrenyl-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98% |
[864943-22-6] |
50mg |
咨询 |
3-5周 |
| ZMR-15-0378 |
(11bR)-2,6-Di-9-anthracenyl-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 95% (99% ee) |
[1011465-29-4] |
50mg |
咨询 |
3-5周 |
| ZMR-15-0362 |
(11bR)-2,6-Bis(3,5-dichlorophenyl)-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 95% (99% ee) |
[1191451-24-7] |
50mg |
咨询 |
3-5周 |
| ZMR-15-1373 |
(11bR)-2,6-Bis(3,5-dimethylphenyl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98%, (99% ee) |
[1065214-95-0] |
100mg |
咨询 |
3-5周 |
| ZMR-15-0418 |
(11bR)-2,6-Bis([1,1'-biphenyl]-4-yl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98% (99% ee) |
[861909-35-5] |
50mg |
咨询 |
3-5周 |
| ZMR-15-8524 |
(11bR)-2,6-Bis[2-methoxyphenyl-5-(tert-butyl)]-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98%, (99% ee) |
N/A |
100mg |
咨询 |
3-5周 |
| ZMR-15-0554 |
(11bR)-2,6-Bis[3,5-bis(1,1-dimethylethyl)-4-methoxyphenyl]-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98% (99% ee) |
[957790-93-1] |
50mg |
咨询 |
3-5周 |
| ZMR-15-0562 |
(11bR)-2,6-Bis[3,5-bis(1,1-dimethylethyl)phenyl]-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98% |
[861909-39-9] |
100mg |
咨询 |
3-5周 |
| ZMR-15-1366 |
(11bR)-2,6-Bis[3,5-bis(trifluoromethyl)phenyl]-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98%, (99% ee) |
[791616-62-1] |
100mg |
咨询 |
3-5周 |
| ZMR-15-1376 |
(11bR)-2,6-Bis[3,5-bis(trifluoromethyl)phenyl]-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98%, (99% ee) |
[1011465-24-9] |
100mg |
咨询 |
3-5周 |
| ZMR-15-0388 |
(11bR)-2,6-Bis[4-(2-naphthalenyl)phenyl]-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98% (99% ee) |
N/A |
50mg |
咨询 |
3-5周 |
| ZMR-15-8520 |
(11bR)-2,6-Bis[4-(9-anthracenyl)-2,6-bis(isopropyl)phenyl]-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 95%, (99% ee) |
[1236191-19-7] |
10mg |
咨询 |
3-5周 |
| ZMR-15-0392 |
(11bR)-2,6-Bis[4-(tert-butyl)phenyl]-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98% |
[1569807-27-7] |
50mg |
咨询 |
3-5周 |
| ZMR-07-0380 |
(11bR)-4,4-Dibutyl-2,6-bis(3,4,5-trifluorophenyl)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepinium bromide |
[887938-70-7] |
50mg |
咨询 |
约4周 |
| ZMR-15-0567 |
(11bR)-4-Oxide-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-2,6-bis(2,3,4,5,6-pentafluorophenyl)-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 95%, (99% ee) |
[1284293-46-4] |
25mg |
咨询 |
3-5周 |
| ZMR-15-1388 |
(11bR)-4-Hydroxy-2,6-di-1-naphthalenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98%, (99% ee) |
[864943-23-7] |
100mg |
咨询 |
3-5周 |
| ZMR-15-1390 |
(11bR)-4-Hydroxy-2,6-di-2-naphthalenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98%, (99% ee) |
[791616-56-3] |
100mg |
咨询 |
3-5周 |
| ZMR-15-1386 |
(11bR)-4-Hydroxy-2,6-diphenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98%, (99% ee) |
[695162-86-8] |
100mg |
咨询 |
3-5周 |
| ZMR-15-1398 |
(11bR)-4-Hydroxy-2,6-bis(2,3,4,5,6-pentafluorophenyl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98%, (99% ee) |
[1284293-45-3] |
50mg |
咨询 |
3-5周 |
| ZMR-15-3712 |
(11bR)-4-Hydroxy-2,6-bis(2,4,6-trimethylphenyl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98%, (99% ee) |
[695162-87-9] |
50mg |
咨询 |
3-5周 |
| ZMR-15-8548 |
(11bR)-4-Hydroxy-2,6-bis(2,4,6-trimethoxyphenyl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98% |
N/A |
100mg |
咨询 |
3-5周 |
| ZMR-15-8544 |
(11bR)-4-Hydroxy-2,6-bis(2,6-dimethoxyphenyl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98% |
N/A |
100mg |
咨询 |
3-5周 |
| ZMR-15-0309 |
(11bR)-4-Hydroxy-2,6-bis(4-methoxyphenyl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98%, (99% ee) |
[695162-88-0] |
50mg |
咨询 |
3-5周 |
